Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Sirnaomics Ltd. ( (HK:2257) ) is now available.
Sirnaomics Ltd. has announced the appointment of Mr. Ouyang Yunlong as a non-executive director and Dr. Zhang Peng as an independent non-executive director, both effective from July 3, 2025. These appointments are expected to strengthen the company’s leadership in the biomedical industry, leveraging Mr. Ouyang’s extensive experience in financial management and venture capital investment, and Dr. Zhang’s expertise, to enhance strategic decision-making and industry positioning.
More about Sirnaomics Ltd.
Sirnaomics Ltd. operates in the biomedical industry, focusing on venture capital investment and project management in the field. The company is involved in raising and managing venture capital funds in both RMB and USD, indicating a strong market focus on financial growth and investment in biomedical innovations.
Average Trading Volume: 254,948
Technical Sentiment Signal: Hold
Current Market Cap: HK$476.4M
Learn more about 2257 stock on TipRanks’ Stock Analysis page.